• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD133 诱导 TM4SF5 表达通过招募和阻断蛋白酪氨酸磷酸酶受体 F(PTPRF)促进球体生长。

CD133-induced TM4SF5 expression promotes sphere growth via recruitment and blocking of protein tyrosine phosphatase receptor type F (PTPRF).

机构信息

Department of Pharmacy, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.

Department of Pharmacy, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Systems Biotechnology Research Center, Korea Institute of Science and Technology (KIST), Gangneung-si, Gangwon-do, 25451, Republic of Korea.

出版信息

Cancer Lett. 2018 Dec 1;438:219-231. doi: 10.1016/j.canlet.2018.09.009. Epub 2018 Sep 11.

DOI:10.1016/j.canlet.2018.09.009
PMID:30217560
Abstract

CD133 is a surface marker of liver cancer stem cells. Transmembrane 4 L six family member 5 (TM4SF5) promotes sphere growth and circulation. However, it is unknown how CD133 and TM4SF5 cross-talk with each other for cancer stem cell properties. Here, we investigated the significance of inter-relationships between CD133, TM4SF5, CD44, and protein tyrosine phosphatase receptor type F (PTPRF) in a three-dimensional (3D) sphere growth system. We found that CD133 upregulated TM4SF5 and CD44, whereas TM4SF5 and CD44 did not affect CD133 expression. Signaling activity following CD133 phosphorylation caused TM4SF5 expression and sphere growth. TM4SF5 bound to CD133 and promoted c-Src activity for CD133 phosphorylation as a positive feedback loop, leading to CD133-mediated sphere growth that was inhibited by TM4SF5 inhibition or suppression. TM4SF5 also bound PTPRF and promoted paxillin phosphorylation. Decreased sphere growth upon CD133 suppression was recovered by TM4SF5 expression and partially by PTPRF suppression. TM4SF5 inhibition enhanced PTPRF levels and abolished PTPRF suppression-mediated sphere growth. Altogether, CD133-induced TM4SF5 expression and function were important for liver cancer sphere growth and may be a promising target to block metastasis.

摘要

CD133 是肝癌干细胞的表面标志物。跨膜 4L 六家族成员 5(TM4SF5)促进球体生长和循环。然而,CD133 和 TM4SF5 如何相互作用以维持癌症干细胞特性尚不清楚。在这里,我们在三维(3D)球体生长系统中研究了 CD133、TM4SF5、CD44 和蛋白酪氨酸磷酸酶受体 F(PTPRF)之间相互关系的意义。我们发现 CD133 上调 TM4SF5 和 CD44,而 TM4SF5 和 CD44 并不影响 CD133 的表达。CD133 磷酸化后的信号活性导致 TM4SF5 的表达和球体生长。TM4SF5 与 CD133 结合并促进 c-Src 活性以促进 CD133 磷酸化,形成正反馈环,导致 CD133 介导的球体生长,TM4SF5 的抑制或下调可抑制该生长。TM4SF5 还与 PTPRF 结合并促进桩蛋白磷酸化。CD133 抑制后球体生长的减少可通过 TM4SF5 的表达部分恢复,通过 PTPRF 的抑制部分恢复。TM4SF5 抑制增强了 PTPRF 水平,并消除了 PTPRF 抑制介导的球体生长。总之,CD133 诱导的 TM4SF5 表达和功能对肝癌球体生长很重要,可能是阻止转移的有前途的靶点。

相似文献

1
CD133-induced TM4SF5 expression promotes sphere growth via recruitment and blocking of protein tyrosine phosphatase receptor type F (PTPRF).CD133 诱导 TM4SF5 表达通过招募和阻断蛋白酪氨酸磷酸酶受体 F(PTPRF)促进球体生长。
Cancer Lett. 2018 Dec 1;438:219-231. doi: 10.1016/j.canlet.2018.09.009. Epub 2018 Sep 11.
2
The COOH-terminus of TM4SF5 in hepatoma cell lines regulates c-Src to form invasive protrusions via EGFR Tyr845 phosphorylation.肝癌细胞系中TM4SF5的羧基末端通过表皮生长因子受体酪氨酸845磷酸化调节c-Src以形成侵袭性突起。
Biochim Biophys Acta. 2013 Mar;1833(3):629-42. doi: 10.1016/j.bbamcr.2012.11.026. Epub 2012 Dec 6.
3
Self-renewal and circulating capacities of metastatic hepatocarcinoma cells required for collaboration between TM4SF5 and CD44.TM4SF5与CD44协作所需的转移性肝癌细胞的自我更新和循环能力。
BMB Rep. 2015 Mar;48(3):127-8. doi: 10.5483/bmbrep.2015.48.3.047.
4
Interaction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells.四跨膜结构域 5(TM4SF5)与 CD44 的相互作用促进肝癌细胞的自我更新和循环能力。
Hepatology. 2015 Jun;61(6):1978-97. doi: 10.1002/hep.27721. Epub 2015 Mar 18.
5
N-terminus-independent activation of c-Src via binding to a tetraspan(in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application.通过与肝癌中的四跨膜蛋白 5(TM4SF5)结合,实现 c-Src 的 N 端非依赖性激活,该激活可被 TM4SF5 C 端肽的应用所阻断。
Theranostics. 2021 Jul 6;11(16):8092-8111. doi: 10.7150/thno.58739. eCollection 2021.
6
Functional genomics identified a novel protein tyrosine phosphatase receptor type F-mediated growth inhibition in hepatocarcinogenesis.功能基因组学鉴定了一种新型蛋白酪氨酸磷酸酶受体 F 介导的肝癌发生中的生长抑制作用。
Hepatology. 2014 Jun;59(6):2238-50. doi: 10.1002/hep.27030. Epub 2014 Apr 25.
7
ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.ELK3通过靶向缺氧诱导因子-1α(HIF-1α)促进肝癌干细胞的迁移和侵袭。
Oncol Rep. 2017 Feb;37(2):813-822. doi: 10.3892/or.2016.5293. Epub 2016 Dec 7.
8
Cross talk between the TM4SF5/focal adhesion kinase and the interleukin-6/STAT3 pathways promotes immune escape of human liver cancer cells.TM4SF5/黏着斑激酶与白细胞介素-6/STAT3 通路的串扰促进人肝癌细胞的免疫逃逸。
Mol Cell Biol. 2014 Aug;34(16):2946-60. doi: 10.1128/MCB.00660-14. Epub 2014 Jun 9.
9
miR-647 inhibits hepatocellular carcinoma cell progression by targeting protein tyrosine phosphatase receptor type F.miR-647 通过靶向蛋白酪氨酸磷酸酶受体 F 抑制肝癌细胞进展。
Bioengineered. 2022 Jan;13(1):1090-1102. doi: 10.1080/21655979.2021.2017628.
10
CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure.CD44/CD133 阳性结直肠肿瘤干细胞对氟尿苷的敏感性。
Sci Rep. 2019 Oct 16;9(1):14861. doi: 10.1038/s41598-019-50968-6.

引用本文的文献

1
Isoxazole-based molecules restore NK cell immune surveillance in hepatocarcinogenesis by targeting TM4SF5 and SLAMF7 linkage.基于异恶唑的分子通过靶向TM4SF5和SLAMF7连接来恢复肝癌发生过程中的自然杀伤细胞免疫监视。
Signal Transduct Target Ther. 2025 Jan 20;10(1):15. doi: 10.1038/s41392-024-02106-6.
2
CD44 and its implication in neoplastic diseases.CD44 及其在肿瘤性疾病中的意义。
MedComm (2020). 2024 May 23;5(6):e554. doi: 10.1002/mco2.554. eCollection 2024 Jun.
3
Functional Roles of CD133: More than Stemness Associated Factor Regulated by the Microenvironment.
CD133 的功能作用:不只是微环境调控的干性相关因子
Stem Cell Rev Rep. 2024 Jan;20(1):25-51. doi: 10.1007/s12015-023-10647-6. Epub 2023 Nov 3.
4
Systemic TM4SF5 overexpression in Apc mice promotes hepatic portal hypertension associated with fibrosis.系统性 TM4SF5 过表达在 Apc 小鼠中促进与纤维化相关的肝门静脉高压。
BMB Rep. 2022 Dec;55(12):609-614. doi: 10.5483/BMBRep.2022.55.12.104.
5
CD44 Glycosylation as a Therapeutic Target in Oncology.CD44糖基化作为肿瘤治疗靶点
Front Oncol. 2022 Jul 21;12:883831. doi: 10.3389/fonc.2022.883831. eCollection 2022.
6
Crosstalk between TM4SF5 and GLUT8 regulates fructose metabolism in hepatic steatosis.TM4SF5 与 GLUT8 之间的串扰调节肝脂肪变性中的果糖代谢。
Mol Metab. 2022 Apr;58:101451. doi: 10.1016/j.molmet.2022.101451. Epub 2022 Feb 2.
7
TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes.TM4SF5 介导的肝恶性肿瘤涉及 NK 细胞耗竭样表型。
Cell Mol Life Sci. 2021 Dec 18;79(1):49. doi: 10.1007/s00018-021-04051-x.
8
The role of CD133 in hepatocellular carcinoma.CD133 在肝细胞癌中的作用。
Cancer Biol Ther. 2021 Apr 3;22(4):291-300. doi: 10.1080/15384047.2021.1916381. Epub 2021 Apr 25.
9
Advances in Liver Cancer Stem Cell Isolation and their Characterization.肝癌干细胞的分离及其鉴定进展。
Stem Cell Rev Rep. 2021 Aug;17(4):1215-1238. doi: 10.1007/s12015-020-10114-6. Epub 2021 Jan 11.
10
Amino acid transporters as tetraspanin TM4SF5 binding partners.氨基酸转运蛋白作为四跨膜蛋白 4 家族 5 的结合伴侣。
Exp Mol Med. 2020 Jan;52(1):7-14. doi: 10.1038/s12276-019-0363-7. Epub 2020 Jan 20.